Main > A1. CORP. INDEX. S-Sm > Sierra Oncology Inc./P C2

This data is not available for free

Sierra Oncology Inc./P C2's subsections
2017. 05.30. Patent
2018. 08.22. Acq. Momelotinib
2019. 11.07. Acq. Momelotinib
2022. 04.13. Acq. By GSK
web-site

Sierra Oncology Inc./P C2's products
This section has no products